 | Olivier PeyrousetHospice Civil de Lyon, Département d'Anesthésie Réanimation, Centre Hospitalier Lyon-Sud, Lyon, France. | ALIMA, Dakar, Senegal | Service de Réanimation Médicale,Faculty ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Olivier Peyrouset:Expert Impact
Concepts for whichOlivier Peyrousethas direct influence:Cuff pressure,Experimental treatment,Intracuff pressure,Viral load patients,Ebola virus disease,Patients evd,Patients favipiravir,Jiki trial.
Olivier Peyrouset:KOL impact
Concepts related to the work of other authors for whichfor which Olivier Peyrouset has influence:Ebola virus,Cuff pressure,Sore throat,Lung ultrasound,Endotracheal tube,Tracheal intubation,Viral load.
KOL Resume for Olivier Peyrouset
| Year | |
|---|---|
| 2021 | Hospice Civil de Lyon, Département d'Anesthésie Réanimation, Centre Hospitalier Lyon-Sud, Lyon, France. |
| 2016 | ALIMA, Dakar, Senegal |
| 2006 | Service de Réanimation Médicale,Faculty Paris-Ouest, Hôpital Ambroise-Paré, 92100, Boulogne, France |
| 2001 | * Assistant Professor, † Fellow, ‡ Staff Anesthesiologist, § Professor, ∥ Professor and Head. Received from the Department of Anesthesia, Hôpital Henri Mondor, Créteil, France. |
| Concept | World rank |
|---|---|
| tracheal morbidity | #11 |
| oxide cuff | #14 |
| nitrous oxide cuff | #19 |
| increase cuff pressure | #21 |
| cuff endotracheal tube | #21 |
| throat tracheal | #23 |
| nitrous oxide diffusion | #28 |
| concept guinea | #34 |
| doi 101371 journalpmed1001967 | #34 |
| jiki trial concept | #34 |
| disease jiki | #34 |
| historically controlled guinea | #34 |
| 101371 journalpmed1001967 | #34 |
| correction experimental treatment | #34 |
| guinea article | #42 |
| 005 tracheal | #43 |
| cuff endotracheal | #53 |
| increase cuff | #54 |
| pressure nitrous | #57 |
| trial historically | #58 |
| experimental treatment favipiravir | #60 |
| favipiravir ebola | #62 |
| jiki trial | #71 |
| jiki | #77 |
| load favipiravir | #87 |
| tracheal damage | #98 |
| arm proof | #99 |
Prominent publications by Olivier Peyrouset
BACKGROUND: Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the World Health Organization released a short list of drugs suitable for EVD research. Favipiravir, an antiviral developed for the treatment of severe influenza, was one of these. In late 2014, the conditions for starting a randomized Ebola trial were not fulfilled for two reasons. One was the perception ...
| Known for Viral Load Patients | Experimental Treatment | Ebola Virus Disease | Historically Controlled | Favipiravir Day |
BACKGROUND: Diffusion of nitrous oxide into the cuff of the endotracheal tube results in an increase in cuff pressure. Excessive endotracheal tube cuff pressure may impair tracheal mucosal perfusion and cause tracheal damage and sore throat. Filling the cuff of the endotracheal tube with saline instead of air prevents the increase in cuff pressure due to nitrous oxide diffusion. This method was used to test whether tracheal morbidity is related to excess in tracheal cuff pressure during ...
| Known for Cuff Pressure | Nitrous Oxide | Extubation Patients | Tracheal Morbidity | Sore Throat |
[This corrects the article DOI: 10.1371/journal.pmed.1001967.].
| Known for Ebola Virus Disease |
| Known for Lung Ultrasound | Computed Ultrasonography |
BACKGROUND: Postanesthesia Care Unit (PACU) is an environment associated with an important workload which is susceptible to lead to task interruption (TI), leading to task-switching or concurrent multitasking. The objective of the study was to determine the predictors of the reaction of the nurses facing TI and assess those who lead to an alteration of the initial task.
METHODS: We conducted a prospective observational study into the PACU of a university hospital during February 2017. ...
| Known for Task Interruption |
